Diabetes-related changes in the protein composition and the biomechanical properties of human retinal vascular basement membranes

PLoS One. 2017 Dec 28;12(12):e0189857. doi: 10.1371/journal.pone.0189857. eCollection 2017.

Abstract

Basement membranes (BMs) are specialized sheets of extracellular matrix that outline epithelial cell layers, muscle fibers, blood vessels, and peripheral nerves. A well-documented histological hallmark of progressing diabetes is a major increase in vascular BM thickness. In order to investigate whether this structural change is accompanied by a change in the protein composition, we compared the proteomes of retinal vascular BMs from diabetic and non-diabetic donors by using LC-MS/MS. Data analysis showed that seventeen extracellular matrix (ECM)-associated proteins were more abundant in diabetic than non-diabetic vascular BMs. Four ECM proteins were more abundant in non-diabetic than in diabetic BMs. Most of the over-expressed proteins implicate a complement-mediated chronic inflammatory process in the diabetic retinal vasculature. We also found an up-regulation of norrin, a protein that is known to promote vascular proliferation, possibly contributing to the vascular remodeling during diabetes. Many of the over-expressed proteins were localized to microvascular aneurisms. Further, the overall stoichiometry of proteins was changed, such that the relative abundance of collagens in BMs from diabetic patients was higher than normal. Biomechanical measurements of vascular BM flat mounts using AFM showed that their outer surface was softer than normal.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Basement Membrane / metabolism*
  • Case-Control Studies
  • Chromatography, Liquid
  • Diabetes Mellitus / metabolism*
  • Eye Proteins / metabolism*
  • Humans
  • Microscopy, Atomic Force
  • Proteome
  • Retinal Vessels / metabolism*
  • Retinal Vessels / pathology
  • Tandem Mass Spectrometry

Substances

  • Eye Proteins
  • Proteome

Grants and funding

The project was supported by an in-house grant from the Eye Clinic of the University Basel, Switzerland and by a grant from Bayer (Switzerland).